VitaSpring Biomedical Co. Ltd. (VSBC)

USD 16.0

(0.0%)

Market Cap (In USD)

3.31 Billion

Revenue (In USD)

-

Net Income (In USD)

-

Avg. Volume

-

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
15.0-16.0
PE
-
EPS
-
Beta Value
1.129
ISIN
US92851B1026
CUSIP
92851B102
CIK
1697884
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Jer-Li Lin
Employee Count
-
Website
https://www.vitaspringbio.com
Ipo Date
2019-11-13
Details
VitaSpring Biomedical Co. Ltd. focuses on the development of drugs of cell medicine. The company was formerly known as Shemn Corp. and changed its name to VitaSpring Biomedical Co. Ltd. in February 2020. VitaSpring Biomedical Co. Ltd. was incorporated in 2016 and is headquartered in Irvine, California.